Episode Details
Back to Episodes
Telehealth Access to Mifepristone Faces Supreme Court Showdown
Description
Telehealth access to mifepristone, a pill for ending pregnancies before ten weeks, is under fire. Louisiana sued to block a new rule allowing docs to prescribe it without in-person visits, but the Fifth Circuit Court paused it nationwide. However, Supreme Court Justice Samuel Alito kept access open until May eleventh. Anti-abortion states argue it interferes with their bans and the FDA rushed the process. Providers and patients feel the heat, with twenty-seven percent of early 2025 abortions via telehealth. Drug companies are pushing for quick Supreme Court review, which could reshape access nationwide. Stay tuned as the justices drop their next play.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/69f53029077036a7